諾思格(301333.SZ):擬參設產業基金 投資於早中期生物醫藥創新及醫療器械公司等醫療健康行業
格隆匯2月19日丨諾思格(301333.SZ)公佈,公司於2024年2月19日召開第四屆董事會第十七次會議,審議通過了《關於與專業機構共同投資設立產業基金的議案》,董事會同意公司與中金資本共同投資設立產業基金中金諾思格盛和(北京)合夥企業(有限合夥)(暫定名,最終名稱以市場監督管理部門登記為準,簡稱“本次對外投資”)。
產業基金目標認繳資金規模不低於人民幣5億元,初始認繳規模人民幣3.15億元。公司全資子公司諾思格投資擬擔任產業基金的有限合夥人,公司全資子公司諾禾諮詢與中金資本共同擔任產業基金的普通合夥人,諾思格投資與諾禾諮詢擬認繳的出資額不超過產業基金認繳出資總額的30.00%,且任何情況下不超過人民幣1.20億元,中金資本作為普通合夥人擬認繳的出資額為人民幣500萬元,剩餘部分擬向其他意向方募集。基金專注投資於早中期生物醫藥創新及醫療器械公司等醫療健康行業。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.